Ascendis Pharma A ASND Earnings Call Transcripts

NASDAQ ASND
$256.55 -3.30 (-1.27%)
At close: Nov 10, 2026 · 4:00 PM EST
12 earnings calls on file for Ascendis Pharma A, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Ascendis Pharma A Q2 2026 Earnings Call

Aug 13, 2026 7,782 words · 34 min read
  • Chad FugureVice President of Investor Relations
  • Jan MikkelsenPresident and Chief Executive Officer
  • Scott SmithChief Financial Officer
  • Sherrie GlassChief Business Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Ascendis Pharma A Earnings Call Transcripts

Calls12
LatestAug 13, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 12 Ascendis Pharma A transcripts Register to get access to Ascendis Pharma A’s earnings call transcripts.